Nuveen Asset Management LLC boosted its stake in Vital Farms, Inc. (NASDAQ:VITL - Free Report) by 21.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 733,952 shares of the company's stock after acquiring an additional 129,621 shares during the period. Nuveen Asset Management LLC owned 1.68% of Vital Farms worth $27,663,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently modified their holdings of VITL. CIBC Private Wealth Group LLC grew its stake in shares of Vital Farms by 152.1% in the 4th quarter. CIBC Private Wealth Group LLC now owns 895 shares of the company's stock worth $35,000 after purchasing an additional 540 shares during the last quarter. US Bancorp DE increased its holdings in Vital Farms by 160.3% in the 4th quarter. US Bancorp DE now owns 1,416 shares of the company's stock valued at $53,000 after buying an additional 872 shares during the period. Frazier Financial Advisors LLC acquired a new stake in shares of Vital Farms in the 4th quarter valued at $59,000. Principal Securities Inc. boosted its stake in shares of Vital Farms by 29.4% in the 4th quarter. Principal Securities Inc. now owns 1,673 shares of the company's stock valued at $63,000 after purchasing an additional 380 shares in the last quarter. Finally, Rothschild Investment LLC lifted its position in Vital Farms by 191.2% during the 4th quarter. Rothschild Investment LLC now owns 1,814 shares of the company's stock worth $68,000 after buying an additional 1,191 shares in the last quarter. Institutional investors own 98.59% of the company's stock.
Insider Buying and Selling
In other news, CEO Russell Diez-Canseco sold 45,124 shares of the stock in a transaction dated Monday, April 14th. The shares were sold at an average price of $33.69, for a total transaction of $1,520,227.56. Following the transaction, the chief executive officer now owns 703,736 shares of the company's stock, valued at $23,708,865.84. This represents a 6.03% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Matthew Ohayer sold 4,000 shares of the firm's stock in a transaction dated Monday, March 24th. The shares were sold at an average price of $31.39, for a total transaction of $125,560.00. Following the completion of the transaction, the insider now directly owns 6,966,890 shares in the company, valued at approximately $218,690,677.10. The trade was a 0.06% decrease in their position. The disclosure for this sale can be found here. Insiders sold 93,124 shares of company stock worth $3,019,308 in the last quarter. Insiders own 27.60% of the company's stock.
Vital Farms Trading Down 2.7%
Shares of VITL stock traded down $0.89 on Wednesday, reaching $32.25. 67,288 shares of the stock were exchanged, compared to its average volume of 1,023,386. Vital Farms, Inc. has a 1-year low of $27.91 and a 1-year high of $48.41. The stock has a market cap of $1.44 billion, a P/E ratio of 28.80 and a beta of 0.94. The company has a quick ratio of 2.81, a current ratio of 3.24 and a debt-to-equity ratio of 0.04. The firm has a 50 day moving average of $33.32 and a two-hundred day moving average of $35.02.
Vital Farms (NASDAQ:VITL - Get Free Report) last announced its earnings results on Thursday, May 8th. The company reported $0.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.26 by $0.11. The company had revenue of $162.19 million for the quarter, compared to the consensus estimate of $164.43 million. Vital Farms had a net margin of 8.68% and a return on equity of 22.29%. The company's revenue was up 9.7% on a year-over-year basis. During the same period in the previous year, the business earned $0.43 EPS. On average, research analysts anticipate that Vital Farms, Inc. will post 1.11 EPS for the current year.
Wall Street Analysts Forecast Growth
Several equities analysts recently weighed in on VITL shares. Telsey Advisory Group reissued an "outperform" rating and issued a $52.00 target price on shares of Vital Farms in a research note on Monday, May 5th. William Blair restated an "outperform" rating on shares of Vital Farms in a report on Friday, February 28th. Morgan Stanley decreased their target price on Vital Farms from $40.00 to $39.00 and set an "overweight" rating for the company in a research report on Thursday, April 17th. Stifel Nicolaus upgraded Vital Farms from a "hold" rating to a "buy" rating and set a $44.00 price target for the company in a research report on Friday, February 28th. Finally, DA Davidson decreased their price target on Vital Farms from $44.00 to $42.00 and set a "buy" rating on the stock in a research note on Friday, March 14th. Eight analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, Vital Farms presently has an average rating of "Buy" and a consensus target price of $44.63.
Read Our Latest Report on VITL
Vital Farms Profile
(
Free Report)
Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.
See Also

Before you consider Vital Farms, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vital Farms wasn't on the list.
While Vital Farms currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.